These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1065 related items for PubMed ID: 9725263

  • 41. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C, Allard A, Brochu S, Poupart C, Fontaine P, Bélanger R, Gyger M.
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [Abstract] [Full Text] [Related]

  • 42. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 43. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
    Friedman TM, Gilbert M, Briggs C, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):41-8. PubMed ID: 9647205
    [Abstract] [Full Text] [Related]

  • 44. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.
    Erdmann AA, Jung U, Foley JE, Toda Y, Fowler DH.
    Biol Blood Marrow Transplant; 2004 Sep 01; 10(9):604-13. PubMed ID: 15319772
    [Abstract] [Full Text] [Related]

  • 45. Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice.
    Drobyski WR, Vodanovic-Jankovic S, Klein J.
    J Immunol; 2000 Aug 01; 165(3):1634-40. PubMed ID: 10903774
    [Abstract] [Full Text] [Related]

  • 46. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S, Baron C, Hétu F, Roy DC, Perreault C.
    J Immunol; 1995 Dec 01; 155(11):5104-14. PubMed ID: 7594519
    [Abstract] [Full Text] [Related]

  • 47. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar 01; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 48. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS.
    Nat Med; 2003 Sep 01; 9(9):1144-50. PubMed ID: 12925844
    [Abstract] [Full Text] [Related]

  • 49. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL, Forman J.
    J Immunol; 1990 Mar 01; 144(5):2018-26. PubMed ID: 1968493
    [Abstract] [Full Text] [Related]

  • 50. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W, Yang Y, Zhang F, Li YC, Zhou R, Wang JX, Zhu YN, Li XY, Yang YF, Zuo JP.
    Int Immunopharmacol; 2005 Dec 01; 5(13-14):1904-13. PubMed ID: 16275625
    [Abstract] [Full Text] [Related]

  • 51. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2003 Apr 01; 9(4):243-56. PubMed ID: 12720217
    [Abstract] [Full Text] [Related]

  • 52. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B, He Y, Wu Y, Bao G, Liu H, Welniak LA, Murphy WJ.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):772-81. PubMed ID: 20197103
    [Abstract] [Full Text] [Related]

  • 53. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S, Kamisaku H, Sado T.
    Bone Marrow Transplant; 1995 Oct 01; 16(4):603-9. PubMed ID: 8528179
    [Abstract] [Full Text] [Related]

  • 54. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC, Hoffman RA, McCarthy SA, Simmons RL.
    Transplantation; 1995 Jan 27; 59(2):268-73. PubMed ID: 7839451
    [Abstract] [Full Text] [Related]

  • 55. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec 27; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

  • 56. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
    Schlegel PG, Vaysburd M, Chen Y, Butcher EC, Chao NJ.
    J Immunol; 1995 Oct 15; 155(8):3856-65. PubMed ID: 7561092
    [Abstract] [Full Text] [Related]

  • 57. Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD.
    Fujimura J, Takeda K, Kaduka Y, Saito M, Akiba H, Yagita H, Yamashiro Y, Shimizu T, Okumura K.
    Pediatr Transplant; 2010 Jun 15; 14(4):540-8. PubMed ID: 20136724
    [Abstract] [Full Text] [Related]

  • 58. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M.
    Haematologica; 1998 Mar 15; 83(3):197-203. PubMed ID: 9573672
    [Abstract] [Full Text] [Related]

  • 59. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P, Vourka-Karussis U, Weiss L, Slavin S.
    J Immunol; 1993 Nov 01; 151(9):4803-10. PubMed ID: 8409438
    [Abstract] [Full Text] [Related]

  • 60. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A, Spiess S, Conradt P, Claesson MH, Reimann J.
    Eur J Immunol; 1991 Jul 01; 21(7):1591-600. PubMed ID: 1829409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.